Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Blatt J, Gold SH, Wiley JM, Monahan PE, Cooper HC, Harvey D
Bone Marrow Transplant 2001;28(4):405-407.
Review by M. Aldouri
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.